OT Equity Analysis | A.S. Bryden and Sons Holdings Limited (JSE: ASBH)

Prepared for Our Today | Capital Markets & Investments Desk May 15 2026

Rating: HOLD   |   Price: ~J$29.55   |   52-Week Range: J$20.00 to J$40.00

The Setup

A.S. Bryden and Sons Holdings Limited is not a company that announces itself quietly. Listed on the Jamaica Stock Exchange in November 2023 by introduction rather than public offer, ASBH arrived on the market as a centennial company with a century of Caribbean distribution behind it and, immediately, began moving to reshape the regional FMCG landscape. Since then, the pace has been notable. The question investors now face is whether the current price level, after a meaningful pullback from its 52-week high, represents a genuine entry point or simply cheap-looking glass on a story that is still working itself out.

The short answer is that it is some of both.

What ASBH Actually Is

ASBH is a regional consumer products distribution company with operations spanning food and grocery, beverages, pharmaceuticals, hardware, housewares, and industrial equipment. It also carries exposure to investment, real estate, logistics, and general insurance activities. The group operates several subsidiaries and affiliates across the Caribbean, including AS Bryden Trinidad and Tobago, Bryden Pi, F.T. Farfan, BPI Guyana, ICON Guyana, Micon Marketing, Armstrong Healthcare, and Stansfeld Scott in Barbados. It is, in practical terms, one of the most diversified distribution conglomerates operating under a single regional umbrella in the English-speaking Caribbean.

The Seprod connection is central to understanding the company’s strategic direction. Seprod is ASBH’s ultimate parent and has been steadily tightening its ownership across the group. Non-controlling interests in Seprod’s consolidated accounts fell sharply from J$17.19 billion to J$10.79 billion in 2025, reflecting the increasing stakes being accumulated up and down the chain. The practical effect is that ASBH is less a standalone listed company and more an operating arm through which Seprod is building a regional distribution platform.

The CPJ Acquisition: Bold Stroke, Complicated Execution

The defining corporate event of the past eighteen months has been ASBH’s acquisition of Caribbean Producers Jamaica Limited. ASBH acquired an additional 30.4 per cent of CPJ via a share swap in late 2024, bringing its total ownership to 75.3 per cent and converting CPJ into a formal subsidiary. The sellers received 94,871,379 newly issued ASBH ordinary shares in exchange. Prior to that, ASBH had already acquired a 44.8 per cent strategic stake in July 2024.

The strategic logic is coherent. CPJ gains access to a regional distribution network, procurement scale, and capital. Bryden gains a premium foothold in Jamaica’s hospitality and food service sector, arguably the most attractive commercial channel on the island for a company in ASBH’s position. The Seprod/Bryden ecosystem that now governs CPJ collectively generates annual revenues of approximately US$750 million and employs over 3,200 people across the region. These are not small numbers.

The execution, however, has carried visible costs. Seprod’s consolidated net profit fell 37 per cent in its second quarter of 2025, even as revenue climbed 26 per cent, with other operating expenses growing 53 per cent over the same period, largely attributed to CPJ acquisition and integration costs. That is the familiar shape of a major acquisition in its first full year of consolidation. The costs are real and they are showing up in the income statement.

There is also a material reporting overhang sitting on the stock right now. CPJ was negatively impacted by Hurricane Melissa in October 2025 and its audited financial statements have not yet been finalised. The delay has created a direct spillover effect on ASBH and ultimately on Seprod, since neither company’s consolidated audited financials can be completed until CPJ’s external audit is done. That audit was expected by today. Investors should watch the JSE filing board closely.

The Numbers

At the last quoted price of approximately J$29.55, ASBH trades at a price-to-earnings ratio of roughly 35.6 times. That is a premium multiple for a distribution business, and it requires some justification from the forward earnings trajectory to be sustainable. Revenue for 2024 came in at J$3.39 billion, a 32 per cent increase over the prior year, while earnings fell 58 per cent to J$53.73 million. That combination, top-line growth being absorbed by bottom-line pressure, illustrates the integration cost dynamic precisely.

The enterprise value stands at approximately J$4.1 billion, with an EV-to-EBIT ratio of roughly 111 times based on trailing EBIT of J$37 million. That figure is elevated, but it reflects the acquisition-related cost drag on current earnings rather than the company’s normalised operating capacity. The 52-week range of J$20.00 to J$40.00 tells its own story about the degree of uncertainty the market has been pricing into the name.

On the liquidity side, there are reasons for measured optimism. Cash provided by operations for the broader Seprod group improved to J$8.22 billion from J$6.07 billion in the prior year, and management completed a J$3 billion capital markets raise in November 2025 to refinance short-term obligations and extend maturities. The balance sheet is stretched from the pace of acquisition, but it is being actively managed.

The Governance Question

With ASBH holding 75.28 per cent of CPJ’s shares, minority investors in CPJ face a concentrated ownership structure that limits their practical influence. Richard Pandohie, CEO of both Seprod Group and AS Bryden, was installed as Chairman of CPJ, and a series of ASBH-linked executives moved through the CPJ CEO role in relatively rapid succession through 2025. For ASBH shareholders themselves, the risk is a different one: ASBH is increasingly a vehicle through which Seprod exercises regional distribution control, and its listed profile on the JSE may, over time, become less independently relevant as the group consolidates further.

That is not necessarily a bad outcome for investors who bought in at the right price. But it is a dynamic worth understanding before sizing a position.

Verdict

ASBH is a genuinely interesting regional holding, sitting at the intersection of Caribbean distribution scale and post-acquisition integration risk. The strategic architecture, Seprod at the top, ASBH as the regional operating arm, CPJ as the Jamaica hospitality and food service anchor, is coherent. If executed well, it could produce meaningful earnings growth over a three to five year horizon.

The near-term picture is cloudier. Valuation multiples are elevated relative to current earnings, the income statement is still absorbing integration costs, and the pending CPJ audit has kept full-year 2025 consolidated financials in limbo. The stock has pulled back meaningfully from its 52-week high, which has improved the margin of safety somewhat, but it has not yet reached a level that compensates adequately for the uncertainty still in the air.

For existing holders, this is a hold, pending the CPJ audit release and evidence of sustainable margin recovery in the quarters ahead. For prospective investors, patience remains the discipline. Let the audited numbers come through, assess the quality of earnings they reveal, and size accordingly. The thesis is not broken. It is still being written.

---

This commentary is prepared for informational and editorial purposes only and does not constitute investment advice. Readers should conduct their own due diligence and consult a licensed financial adviser before making any investment decisions.